Search Results for 'rbv genotype'

rbv genotype published presentations and documents on DocSlides.

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

by UnicornLove

C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...

by min-jolicoeur

Randomisation. Open-label. W8. * Liver biopsy or ...

by debby-jeon

SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....

OBV/PTV/r DSV Open label

OBV/PTV/r DSV Open label

by kittie-lecroy

≥ 18 years. Chronic HCV infection. Genotype 1. ...

FISSION Design Objective

FISSION Design Objective

by travis

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

OBV/PTV/r DSV RBV OBV/PTV/r

OBV/PTV/r DSV RBV OBV/PTV/r

by ellena-manuel

DSV . placebo. Randomisation*. Partial blind. 1...

by ellena-manuel

Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...

C-WORTHY Study Part

C-WORTHY Study Part

by karlyn-bohler

D : . grazoprevir. . + . elbasvir. + RBV in ge...

by tawny-fly

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

by cheryl-pisano

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...

by pasty-toler

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

by test

PTV150/r + OBV + . DSV . + RBV. PTV150/r + . DSV...

SMV 12W + PEG-IFN + RBV 24-48W **

SMV 12W + PEG-IFN + RBV 24-48W **

by alexa-scheidler

SMV 24W + PEG-IFN + RBV 24-48W **. Randomisation ...

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

by badra

Duke University School of Medicine. Durham, North ...

Hepatitis C Imtiaz Alam, M.D.

Hepatitis C Imtiaz Alam, M.D.

by olivia-moreira

Medical Director, Austin Hepatitis Center. 1. Hep...

by pamella-moone

* Liver biopsy or . Fibroscan. ≤. 12.5 . kPa....

by sherrill-nordquist

SOF + SMV + RBV. SOF + SMV. Randomisation. 2 : 1 ...

by stefany-barnette

Randomisation*. Open-label. >. 18 years. HCV ...

by ellena-manuel

X. J . Hepatology. 2015; 63: 564-72. C-SALVAGE ...

by celsa-spraggs

N = 69. >. 18 years. Failure to SOF/VEL . or ...

by kittie-lecroy

Paritaprevir. -. Ritonavir. . and . Dasabuvir. ...

by pamella-moone

*. 1:1. Open-label. ≥ 18 years. HCV genotype ...

by pasty-toler

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

by trish-goza

400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...

by celsa-spraggs

C-WORTHY Study Part C: . grazoprevir. . + . elba...

by tawny-fly

Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...

Future HCV Treatment Paradigms

Future HCV Treatment Paradigms

by kittie-lecroy

Mark Sulkowski, MD . Professor of Medicine. Medic...

Direct Acting Antivirals: What are they? What is their pl

Direct Acting Antivirals: What are they? What is their pl

by tawny-fly

Mark Sulkowski, MD. Associate Professor of Medici...

Reddy KR. Lancet Infect Dis. 2015;15:27-35

Reddy KR. Lancet Infect Dis. 2015;15:27-35

by natalia-silvester

ATTAIN. SMV + TVR placebo. + PEG-IFN + RBV. TVR ...

by myesha-ticknor

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

by aaron

W24. DCV + PR. Placebo + PR. Yes. Dore GJ. Gastro...

Boceprevir with PEG + RBV in Genotype 1

Boceprevir with PEG + RBV in Genotype 1

by caroline

SPRINT. -1. Phase . 2. Treatment. . Naïve. Kwo. ...

Not randomised Open-label

Not randomised Open-label

by cheryl-pisano

18-70 years. HCV genotype 1 or 3. Naïve or failu...

by conchita-marotz

OBV/PTV/r + RBV. Randomisation*. 1 : 1. Open labe...

Are Pan-Genotypic Therapies Ready for Prime Time?

Are Pan-Genotypic Therapies Ready for Prime Time?

by lois-ondreau

3. Rd. International . HIV/Hepatitis . Coinfecti...

by giovanna-bartolotta

OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...

by kittie-lecroy

+ DSV + RBV. No randomisation. Open-label. TOPAZ-...

by pasty-toler

OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...

by giovanna-bartolotta

Genotype . 2. . or 3 . FUSION. Trial. Phase . ...

No randomisation

No randomisation

by tatiana-dople

N = 100. W12. W24. Arm B: . compensated cirrhosis...